載入...
Boceprevir in chronic hepatitis C infection: a perspective review
Boceprevir (Victrelis), from the oral α-ketoamide class of slow-binding reversible hepatitis C virus (HCV)-NS3 protease inhibitors, creates a new class of drugs: direct acting antivirals (DDAs). Boceprevir is highly selective against HCV serine protease. Its use is restricted to genotype 1 HCV infec...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513904/ https://ncbi.nlm.nih.gov/pubmed/23251772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622312441496 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|